Literature DB >> 10865998

Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance?

B Sun1, S H Sun, C C Chan, R R Caspi.   

Abstract

Messenger RNAs for six cytokines (IL-12p40, IFN-gamma, IL-10, IL-4, TNF-alpha and TGF-beta1) expressed in vivo during development of experimental autoimmune uveitis (EAU) were quantitated by PCR in (uncultured) peripheral lymphoid cells and in the eyes of EAU-susceptible Lewis and EAU resistant F344 rats. Disease was induced by immunization with the R16 peptide of IRBP (in RT1B haplotype rats) or with whole IRBP (in all haplotypes). In the periphery, both Lewis and F 344 expressed similar cytokine patterns. In ocular tissues, however, only Lewis expressed elevated type 1 and inflammatory cytokines (IL-12p40, IFN-gamma and TNF-alpha), coincident with onset and peak of disease. Interestingly, naive F344 rats expressed higher basal levels of IL-10 mRNA in the eyes. To examine the possible involvement of this phenomenon in resistance, basal levels of IL-10 vs susceptibility to IRBP were compared in Lewis, BN, DA. F344 and ACI strains. Lewis, BN and DA were susceptible and had low levels of IL-10 mRNA in eyes. F344 and ACI were resistant and expressed high basal levels of IL-10 mRNA. In an in vitro study, recombinant rat IL-10 (but not human or mouse IL-10) suppressed lymphocyte proliferation and IFN-gamma production by primed lymph node cells of R16 immunized rats, but did not suppress uveitogenic long-term T-cell lines polarized to the Thl phenotype, suggesting that mature effector lymphocytes in the rat may lose their ability to be suppressed by IL-10. We propose that higher expression of the IL-10 gene in ocular tissues in some rat strains may represent a mechanism that contributes to a higher threshold of resistance to EAU, but this threshold may be overcome by a more mature Thl effector with a reduced sensitivity to IL-10.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865998     DOI: 10.1006/exer.1999.0808

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  15 in total

1.  Natural recovery from antiglomerular basement membrane glomerulonephritis is associated with glomeruli-infiltrating CD8α+CD11c+MHC class II+ cells.

Authors:  Cindy Zhou; Julie Robertson; Jean Wu; Todd Bartkowiak; Kiana Parker; John McMahon; Ya-Huan Lou
Journal:  Am J Nephrol       Date:  2011-11-07       Impact factor: 3.754

2.  Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.

Authors:  Sara Bar-Yehuda; Dror Luger; Avivit Ochaion; Shira Cohen; Renana Patokaa; Galina Zozulya; Phyllis B Silver; Jose Maria Garcia Ruiz de Morales; Rachel R Caspi; Pnina Fishman
Journal:  Int J Mol Med       Date:  2011-07-19       Impact factor: 4.101

Review 3.  Tregs and infections: on the potential value of modifying their function.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2011-09-13       Impact factor: 4.962

Review 4.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

Review 5.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Murine metal-induced systemic autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains.

Authors:  B Häggqvist; P Hultman
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 7.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

8.  Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis.

Authors:  Mary J Mattapallil; Andrea Augello; Chris Cheadle; Diane Teichberg; Kevin G Becker; Chi-Chao Chan; Joseph J Mattapallil; Giuseppina Pennesi; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-15       Impact factor: 4.799

Review 9.  Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.

Authors:  Rachel R Caspi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.

Authors:  Y De Kozak; B Thillaye-Goldenberg; M-C Naud; A Vianna Da Costa; C Auriault; C Verwaerde
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.